Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BNTC

Benitec Biopharma Inc

Feb 05 • 01:32PM ET

11.80

Dollar change -0.37
Percentage change -3.05	%

Healthcare • Biotechnology • USA • NASD

Peers: MRNA IONS ALNY CRSP ARWR NTLA SRPT EDIT SGMO QURE

| Held by: VXF PINK IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.28	Insider Own	10.79%	Shs Outstand	23.22M	Perf Week	8.54%
Market Cap	273.97M	Forward P/E	-	EPS next Y	-4.15	Insider Trans	5.52%	Shs Float	20.71M	Perf Month	-2.49%
Income	-21.48M	PEG	-	EPS next Q	-0.78	Inst Own	80.47%	Short Float	0.60%	Perf Quarter	8.05%
Sales	0.00M	P/S	-	EPS this Y	52.64%	Inst Trans	77.22%	Short Ratio	2.29	Perf Half Y	47.85%
Book/sh	3.59	P/B	3.29	EPS next Y	-46.12%	ROA	-43.53%	Short Interest	0.12M	Perf Year	319.21%
Cash/sh	2.92	P/C	4.03	EPS next 5Y	7.88%	ROE	-48.23%	52W Range	2.70 - 13.29	Perf YTD	-6.58%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-33.46%	52W High	-11.22%	Beta	0.94
Dividend TTM	-	Quick Ratio	15.01	Sales past 5Y	-42.37%	Gross Margin	-	52W Low	336.99%	ATR (14)	0.65
Dividend Ex-Date	-	Current Ratio	15.01	EPS Y/Y TTM	54.50%	Oper. Margin	-	RSI (14)	57.46	Volatility	4.45% 5.57%
Employees	16	Debt/Eq	0.00	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.14	Target Price	25.43
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	82.78%	Payout	-	Rel Volume	0.42	Prev Close	12.17
Sales Surprise	-	EPS Surprise	12.73%	Sales Q/Q	-	Earnings	Nov 14 AMC	Avg Volume	54.24K	Price	11.80
SMA20	7.45%	SMA50	5.30%	SMA200	23.81%	Trades		Volume	14,678	Change	-3.05%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-16-24	Initiated	H.C. Wainwright	Buy	$28
Dec-13-24	Initiated	Robert W. Baird	Outperform	$30
Oct-16-24	Initiated	Oppenheimer	Outperform	$35
Sep-12-24	Initiated	Guggenheim	Buy	$17
Jul-22-24	Initiated	Leerink Partners	Outperform	$13
Jun-13-24	Initiated	Piper Sandler	Overweight	$30
Oct-05-20	Downgrade	Ladenburg Thalmann	Buy → Neutral
Apr-20-20	Initiated	Ladenburg Thalmann	Buy	$14
Feb-26-16	Downgrade	Maxim Group	Buy → Hold
Dec-31-15	Reiterated	Maxim Group	Buy	$23 → $14
Sep-16-15	Reiterated	Maxim Group	Buy	$4 → $23

Show Previous Ratings

Jan-27-25 08:00AM	Benitec Biopharma to Participate in Upcoming Conferences in January and February (GlobeNewswire)
Jan-13-25 09:49AM	Why You Shouldn't Bet Against Benitec Biopharma (BNTC) Stock (Zacks) -5.55%
Dec-17-24 06:25AM	Benitec Biopharma initiated with a Buy at H.C. Wainwright (TipRanks)
Dec-09-24 09:55AM	Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? (Zacks) +8.46%
08:50AM	Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
07:00AM	Loading…
Nov-26-24 07:00AM	Benitec Biopharma to Participate in Upcoming Investor Conferences in December (GlobeNewswire)
Nov-14-24 04:30PM	Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-04-24 08:00AM	Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference (GlobeNewswire)
Oct-25-24 05:01PM	Janus Henderson Group PLC Expands Investment in Benitec Biopharma Inc (GuruFocus.com)
Oct-14-24 06:00AM	Benitec Biopharma Announces Updated Investor Webcast Information (GlobeNewswire) -6.45%
Oct-12-24 06:30AM	Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society (GlobeNewswire)
Sep-30-24 09:03PM	Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc (GuruFocus.com) +19.42%
Sep-26-24 04:30PM	Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update (GlobeNewswire) +5.01%
Sep-18-24 08:00AM	Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society (GlobeNewswire)
Sep-17-24 08:00AM	Benitec Biopharma CEO to Participate in OPMD Awareness Day Webinar (GlobeNewswire)
06:00AM	Loading…
Jul-15-24 06:00AM	Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study (GlobeNewswire) +7.71%
Jul-01-24 07:00AM	Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors (GlobeNewswire)
May-13-24 02:53PM	BNTC Stock Earnings: Benitec Biopharma Misses EPS for Q3 2024 (InvestorPlace) -12.22%
08:15AM	Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
May-01-24 08:00AM	Benitec Biopharma to Participate in the Citizens JMP Life Science Conference (GlobeNewswire) -6.51%
Apr-18-24 07:30AM	Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study (GlobeNewswire) +42.08%
07:00AM	Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million (GlobeNewswire)
Apr-09-24 08:00AM	Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024 (GlobeNewswire)
Mar-24-24 07:55AM	11 Best ASX Stocks To Buy Now (Insider Monkey)
Feb-13-24 08:00AM	Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-30-23 07:00AM	Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (GlobeNewswire)
Nov-17-23 08:00AM	Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 08:00AM	Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Sep-21-23 08:00AM	Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Aug-21-23 09:02PM	Citadel Advisors LLC Acquires New Stake in Benitec Biopharma Inc (GuruFocus.com)
09:02PM	Loading…
Aug-18-23 09:02PM	JANUS HENDERSON GROUP PLC Acquires New Stake in Benitec Biopharma Inc (GuruFocus.com)
Aug-11-23 01:00PM	Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering (GlobeNewswire)
Aug-08-23 10:30PM	Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering (GlobeNewswire) +65.80%
Jul-25-23 01:00PM	Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023 (GlobeNewswire)
Jun-26-23 08:00AM	Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (GlobeNewswire) +80.90%
May-15-23 08:00AM	Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
May-08-23 08:05AM	Benitec Biopharma to Present at the OPMD International Conference (GlobeNewswire)
08:00AM	Benitec Biopharma to Present at the JMP Securities Life Sciences Conference (GlobeNewswire)
Feb-13-23 08:00AM	Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Jan-23-23 09:48AM	Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program (GlobeNewswire) +9.08%
Nov-10-22 08:00AM	Benitec Biopharma Releases First Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +5.79%
Sep-16-22 08:42AM	Benitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering (GlobeNewswire) -15.43%
Sep-12-22 10:06PM	Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering (GlobeNewswire) -6.63% -28.34%
Sep-02-22 08:00AM	Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update (GlobeNewswire)
Jul-15-22 06:52AM	Having purchased US$827k worth of Benitec Biopharma Inc. (NASDAQ:BNTC) stock, the recent 11% pullback is not what insiders may have expected (Simply Wall St.) +7.00%
May-16-22 08:15AM	Benitec Biopharma Releases Q3 2022 Financial Results (GlobeNewswire) -8.79%
Feb-14-22 08:00AM	Benitec Biopharma Discloses Q2 2022 Financial Results (PR Newswire)
Jan-18-22 12:53PM	/C O R R E C T I O N from Source -- Norra Metals Corp./ (PR Newswire) -6.64%
Jan-17-22 09:30AM	Norra Metals Announces Private Placement Financing (PR Newswire)
Nov-27-21 06:54AM	We're Keeping An Eye On Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate (Simply Wall St.)
Nov-15-21 08:00AM	Benitec Biopharma Discloses Q1 2022 Financial Results (PR Newswire)
Sep-20-21 08:00AM	Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results (PR Newswire) -7.86%
Sep-13-21 03:58PM	Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference (PR Newswire)
Sep-08-21 08:10AM	Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022 (PR Newswire)
08:05AM	Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals (PR Newswire)
08:00AM	Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022 (PR Newswire)
May-31-21 01:54AM	Is Benitec Biopharma (NASDAQ:BNTC) In A Good Position To Invest In Growth? (Simply Wall St.)
Apr-27-21 09:55PM	Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million (PR Newswire) -20.62%
04:44PM	Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock (PR Newswire)
Mar-23-21 12:18PM	5 Top Stock Gainers for Tuesday: Dolphin Entertainment, Benitec (TheStreet.com) +190.28%
07:24AM	Tuesdays Pre-Market: Heres What You Need To Know Before The Market Opens (SmarterAnalyst)
07:09AM	Benitec Shares Skyrocket as Morgan Stanley Takes Stake (TheStreet.com)
Feb-24-21 09:26AM	Benitec Biopharma's Gene Therapy For Rare Muscle Disorder Shows Encouraging Action In Animal Studies (Benzinga) +5.60%
08:29AM	Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study (PR Newswire)
Dec-07-20 02:33PM	Benitec Biopharma Announces 2020 Annual Stockholder Meeting (PR Newswire)
Dec-02-20 12:06AM	A Quick Analysis On Benitec Biopharma's (NASDAQ:BNTC) CEO Compensation (Simply Wall St.)
Oct-06-20 04:05PM	Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares (PR Newswire)
Oct-02-20 09:05AM	Benitec Biopharma Announces Pricing of $10.0 Million Public Offering (PR Newswire) -36.74%
Sep-23-20 04:54PM	Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results (PR Newswire)
Sep-01-20 08:15AM	Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment Conference (PR Newswire)
Jul-08-20 08:00AM	Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study (PR Newswire)
Apr-20-20 06:49AM	Should You Be Concerned About Benitec Biopharma Limited's (NASDAQ:BNTC) Historical Volatility? (Simply Wall St.) +124.78%
Apr-15-20 08:52AM	Benitec Biopharma Announces the Completion of Redomiciliation to the United States (PR Newswire) -10.75%
Apr-14-20 09:28PM	Benitec Biopharma Appoints Edward Smith to the Board of Directors (PR Newswire) -10.31%
Mar-30-20 10:09AM	Benitec Announces Supreme Court of Queensland Approval for Redomicile (PR Newswire)
Mar-26-20 09:44AM	Benitec Announces Results of Scheme Meeting (PR Newswire) +7.60%
Feb-27-20 06:18PM	Is Benitec Biopharma (ASX:BLT) In A Good Position To Deliver On Growth Plans? (Simply Wall St.) +15.11%
Jan-31-20 08:08AM	Appendix 4C: Quarterly Cash Flow Report (PR Newswire) -6.73%
Nov-27-19 08:00AM	ASX/NASDAQ ANNOUNCEMENT: Re-domiciliation to the United States (PR Newswire) -10.17%
Nov-17-19 07:02PM	Some Benitec Biopharma (ASX:BLT) Shareholders Have Taken A Painful 93% Share Price Drop (Simply Wall St.)
Nov-15-19 07:00AM	Public consultation launched on global tailings dam standards (Reuters)
Oct-31-19 08:30AM	Appendix 4C: Quarterly Cash Flow Report (PR Newswire)
Sep-30-19 09:24AM	Benitec Biopharma Limited Announces US$2.25 Million Registered Direct Offering (PR Newswire) -15.24%
Sep-19-19 09:15AM	Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference (PR Newswire) -15.85%
Sep-16-19 08:00AM	Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program (PR Newswire)
Sep-15-19 09:49PM	Does Market Volatility Impact Benitec Biopharma Limited's (ASX:BLT) Share Price? (Simply Wall St.)
Jul-31-19 08:30AM	ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report (PR Newswire) +28.79%
Jul-11-19 11:34PM	Could The Benitec Biopharma Limited (ASX:BLT) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
Jun-06-19 08:09AM	Update on Oculopharyngeal Muscular Dystrophy Program (PR Newswire) -34.18%
May-08-19 08:01PM	Should Benitec Biopharma Limited (ASX:BLT) Be Your Next Stock Pick? (Simply Wall St.)
Mar-06-19 09:52PM	Introducing Benitec Biopharma, The Stock That Tanked 92% (Simply Wall St.)
Jan-29-19 09:46PM	Have Insiders Been Buying Benitec Biopharma Limited (ASX:BLT) Shares This Year? (Simply Wall St.) +6.87%
Dec-21-18 10:10AM	Benitec Provides Update on BB-401 Cancer Treatment Program (PR Newswire) -20.82%
Nov-23-18 12:01AM	Is Benitec Biopharma Limiteds (ASX:BLT) Balance Sheet A Threat To Its Future? (Simply Wall St.)
Nov-15-18 07:35AM	Detailed Research: Economic Perspectives on Knight-Swift Transportation, Benitec Biopharma, Eastern, Kiniksa Pharmaceuticals, Qualstar, and Nomura Holdings Inc ADR What Drives Growth in Today's Competitive Landscape (GlobeNewswire) +7.01%
Sep-19-18 08:00AM	Benitec Biopharma Announces the Appointment of Gregory R. Reyes, M.D., Ph.D. as Senior Scientific Advisor (PR Newswire)
Jul-14-18 02:02PM	3 Biotech Stocks That Soared This Week: Are They Buys? (Motley Fool)
Jul-10-18 05:15PM	Axovant, Benitec Gain on Licensing Deal for Gene Therapy (Zacks)
08:10AM	Today's Research Reports on Stocks to Watch: Benitec Biopharma and Pfizer (ACCESSWIRE)
07:30AM	New Catalysts Could Send This $3 Medical Device Stock to $9 (ACCESSWIRE)

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SUVRETTA CAPITAL MANAGEMENT, L	Director	Dec 23 '24	Buy	10.98	27,502	301,972	7,981,725	Dec 26 04:28 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Dec 24 '24	Buy	11.25	20,018	225,202	7,999,455	Dec 26 04:28 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Dec 03 '24	Buy	9.60	42,000	403,200	7,957,365	Dec 05 04:36 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Nov 20 '24	Buy	10.22	27,436	280,396	7,920,175	Nov 21 04:24 PM
SUVRETTA CAPITAL MANAGEMENT, L	Director	Nov 19 '24	Buy	9.73	14,000	136,220	7,895,815	Nov 21 04:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTC

Benitec Biopharma Inc

Upgrade your FINVIZ experience